Spinal cord damage that causes paralysis and reduced mobility doesnt always stop with the initial trauma, but there are few treatment options to halt increased deterioration and there is no cure. Researchers at Rensselaer Polytechnic Institute have developed a promising new biomaterial that could offer targeted treatment to the damaged spinal cord and tissue, preventing further damage. In research published today (October 23, 2019) in Nature Communications, an interdisciplinary team from Rensselaer demonstrated how estrogen a natural hormone produced in the body can be polymerized into a slow-releasing biomaterial and applied to nervous system cells to protect those cells and even promote regeneration. Continue reading →

Richard Toselli, M.D., President and Chief Executive Officer of InVivo, said, We made a dedicated effort to efficiently activate strategic clinical sites during the first half of the year and are pleased with the resulting pace of enrollment to date, with our team maintaining focus on enrollment efforts and engagement at the site level. In addition, we appreciate the investigators support of this trial, which we believe has the potential to address a long unmet medical need for spinal cord injury patients. About the INSPIRE 2.0 Study The INSPIRE 2.0 Study is a two-arm 20-patient (10 subjects in each study arm), randomized, controlled trial designed to provide clinical data that will supplement the existing clinical results from the companys previous single-arm study (INSPIRE 1.0) Continue reading →

A research trial funded by insurer and care provider icare has shown improvements in emotional being for those who have a spinal cord injury. Read more: icare Foundation funds program for people with spinal cord injury The research trial explored the effect of an internet-delivered pain course on the emotional wellbeing of 69 people with a spinal cord injury, resulting in 30% to 40% improvements in anxiety and depression and 20% to 30% improvements in disability Continue reading →